Abstract
A Step-Down Unit (SDU) provides an intermediate Level of Care for patients from an Intensive Care Unit (ICU) as their condition becomes less acute. SDU congestion, as well as upstream patient arrivals, forces ICU administrators to incur costs, either in the form of overstays or premature step-downs. Basing on a proxy for patient acuity level called the ‘Nine Equivalents of Nursing Manpower Score (NEMS)’, patients were classified into two groups: high-acuity and low-acuity. Two patient flow policies were developed that select actions to optimize the system’s net health service benefit: one allowing for premature step-down actions, and the other allowing for patient rejection actions when the system is congested. The results show that the policy with patient rejection has a net health service benefit that significantly exceeds that of the policy with the premature step-down option. Based on these results, it can be concluded that premature step-down contributes to congestion downstream. Counter-intuitively, premature step-down should therefore be discouraged and patient rejection actions should be further explored as viable options for congested ICUs.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
NSERC Grant
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Research Ethics Review Committee at King's University College.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
(ykobara{at}uwo.ca)
(frodrig7{at}uwo.ca)
(camila.souza{at}uwo.ca)
(stanford{at}stats.uwo.ca)
Data Availability
The data for this study is available from the Critical Care Information System
